A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial on the Efficacy and Safety of PanhematinTM in the Treatment of Acute Attacks of Porphyria

Project: Other project

Project Details

StatusFinished
Effective start/end date11/12/13 → 8/31/21

Funding

  • Recordati Rare Diseases Inc: $380,859.36